Last update :
20/03/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 4919  
Type : Manufacturer
Icone.pdf
721Ko
Research teams :
Authors :
Title : Dostarlimab (Jemperli®) – Résumé des caractéristiques du produits
Reference : 2025
Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 
List of drugs
injectionDostarlimab Anticancer drug
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
Stability in solutions Polypropylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
Stability in solutions Polypropylene NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
Stability in solutions Polyolefine NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
Stability in solutions Polyolefine NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
Stability in solutions Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 2>>10 mg/mL 2-8°C Protect from light
24 Hour
Stability in solutions Ethylene vinyl acetate NaCl 0,9% or Glucose 5% 2>>10 mg/mL 25°C Protect from light
6 Hour
  Mentions Légales